Synapse - Jimmy Nieves

Results (17)

Establishing a standardized system for review and adjudication of chronic graft-vs-host disease data in accordance with the National Institutes Consensus criteria

Journal Article

Dierov, D.; Webb, N.; Fatmi, S.; Nwanne, C.; Ciolino, C.; Mosesso, K.; Nieves, J.; Perales, M. A.; Prockop, S. E.; Ponce, D. M.
Advances in Cell and Gene Therapy (2019)

Fulltext@MSK | Save

Effects of late toxicities on outcomes in long-term survivors of ex-vivo CD34(+)-selected allogeneic hematopoietic cell transplantation

Journal Article

Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Toxicities and outcomes in the first year after ex-vivo CD34+ selected allogeneic hematopoietic cell transplantation in adults with hematologic malignancies

Meeting Abstract

Kosuri, S.; Herrera, D. A. A.; Scordo, M.; Shah, G. L.; Devlin, S. M.; Maloy, M.; Nieves, J.; Cho, C.; Borrill, T.; Carlow, D.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Post-transplant toxicities and outcomes in long-term survivors of ex-vivo CD34+ selected allogeneic hematopoietic cell transplantation

Meeting Abstract

Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Maloy, M.; Nieves, J.; Borrill, T.; Carlow, D.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Immune-mediated hemolytic anemia (IMHA) and immune thrombocytopenia (ITP) after ex-vivo CD34+ selected allogeneic hematopoietic stem cell transplantation

Meeting Abstract

Scordo, M.; Shah, G. L.; Kosuri, S.; Adrianzen Herrera, D. A.; Hsu, M.; Devlin, S. M.; Maloy, M.; Nieves, J.; Borrill, T.; Avecilla, S. T.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Comparable survival with organ toxicity predicting for overall survival (OS) and non-relapse mortality (NRM) in older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation (Allo-HCT)

Meeting Abstract

Shah, G. L.; Scordo, M.; Kosuri, S.; Adrianzen Herrera, D. A.; Cho, C.; Maloy, M.; Nieves, J.; Devlin, S. M.; Borrill, T.; Carlow, D.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Establishing a standardized system to capture chronic graft-versus-host disease (GVHD) data in accordance to the national institutes (NIH) consensus criteria

Meeting Abstract

Dierov, D.; Ciolino, C.; Fatmi, S.; Mosesso, K.; Nieves, J.; Prockop, S.; Perales, M. A.; Webb, N.; Doris, P.
Bone Marrow Transplantation (2017)

Fulltext@MSK | Save

The impact of toxicities on first-year outcomes after ex vivo CD34(+)-selected allogeneic hematopoietic cell transplantation in adults with hematologic malignancies

Journal Article

Kosuri, S.; Herrera, D. A.; Scordo, M.; Shah, G. L.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Carlow, D. C.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Ex vivo CD34(+)–selected T cell–depleted peripheral blood stem cell grafts for allogeneic hematopoietic stem cell transplantation in acute leukemia and myelodysplastic syndrome is associated with low incidence of acute and chronic graft-versus-host disease and high treatment response